- Home
- QBTS vs SCPH Comparison
QBTS vs SCPH Comparison
Compare QBTS & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QBTS
- SCPH
- Stock Information
- Founded
- QBTS 1999
- SCPH 2013
- Country
- QBTS United States
- SCPH United States
- Employees
- QBTS N/A
- SCPH N/A
- Industry
- QBTS Retail: Computer Software & Peripheral Equipment
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- QBTS Technology
- SCPH Health Care
- Exchange
- QBTS Nasdaq
- SCPH Nasdaq
- Market Cap
- QBTS 5.9B
- SCPH 299.0M
- IPO Year
- QBTS N/A
- SCPH 2017
- Fundamental
- Price
- QBTS $17.77
- SCPH $5.63
- Analyst Decision
- QBTS Strong Buy
- SCPH Buy
- Analyst Count
- QBTS 10
- SCPH 3
- Target Price
- QBTS $19.40
- SCPH $12.00
- AVG Volume (30 Days)
- QBTS 31.5M
- SCPH 2.3M
- Earning Date
- QBTS 08-07-2025
- SCPH 11-12-2025
- Dividend Yield
- QBTS N/A
- SCPH N/A
- EPS Growth
- QBTS N/A
- SCPH N/A
- EPS
- QBTS N/A
- SCPH N/A
- Revenue
- QBTS $22,275,000.00
- SCPH $49,969,000.00
- Revenue This Year
- QBTS $182.64
- SCPH $108.95
- Revenue Next Year
- QBTS $52.50
- SCPH $78.30
- P/E Ratio
- QBTS N/A
- SCPH N/A
- Revenue Growth
- QBTS 120.20
- SCPH 107.79
- 52 Week Low
- QBTS $0.87
- SCPH $1.94
- 52 Week High
- QBTS $20.56
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- QBTS 61.46
- SCPH 64.37
- Support Level
- QBTS $14.88
- SCPH $4.33
- Resistance Level
- QBTS $15.96
- SCPH $5.62
- Average True Range (ATR)
- QBTS 0.83
- SCPH 0.05
- MACD
- QBTS 0.24
- SCPH 0.01
- Stochastic Oscillator
- QBTS 93.33
- SCPH 93.75
About QBTS D-Wave Quantum Inc.
D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.